M Helle
Impact in
- Cancer Research top 10%
- Breast Cancer Treatment Studies
- Oncology top 10%
- HER2/EGFR in Cancer Research
Papers in
-
- Glycosylation and Glycoproteins Research 6
- Advanced Biosensing Techniques and Applications 2
-
- Monoclonal and Polyclonal Antibodies Research 8
- Co-authors
- Jorma Isola (10 shared papers)Heikki J. Helin (7 shared papers)Olli Kallioniemi (4 shared papers)Kai Krohn (10 shared papers)Heikki Helin (7 shared papers)Simo Saarakkala (1 shared paper)Heikki Hermunen (1 shared paper)J. M. Koski (1 shared paper)
In The Last Decade
M Helle
30 papers receiving 644 citations
Peers
Comparison fields: 5 of 64
- Cancer Research 170
- Oncology 206
- Reproductive Medicine 53
- Pathology and Forensic Medicine 101
- Rheumatology 76
Countries citing papers authored by M Helle
This map shows the geographic impact of M Helle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Helle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Helle more than expected).
Fields of papers citing papers by M Helle
This network shows the impact of papers produced by M Helle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Helle. The network helps show where M Helle may publish in the future.
Co-authors
The 25 scholars most cited alongside M Helle, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1990 | 150 | |
| 2 | 2006 | 100 | |
| 3 | 1990 | 71 | |
| 4 | 1990 | 59 | |
| 5 | 1999 | 44 | |
| 6 | 1988 | 38 | |
| 7 | 2011 | 28 | |
| 8 | 1997 | 27 | |
| 9 | Proliferative activity and steroid receptors determined by immunohistochemistry in adjacent frozen sections of 102 breast carcinomas. | 1989 | 19 |
| 10 | 1990 | 16 | |
| 11 | Generation of monoclonal antibodies to human milk-fat globule membrane antigens, with special reference to a precipitable secretory product of breast and ovarian carcinomas. | 1985 | 13 |
| 12 | 1990 | 11 | |
| 13 | The use of radiolabelled monoclonal antibodies to human milk fat globule membrane antigens in antibody-guided tumour imaging, and administration of therapeutic dose of labelled antibody in wide-spread ovarian carcinoma. A preliminary report. | 1985 | 10 |
| 14 | 1988 | 9 | |
| 15 | 1986 | 9 | |
| 16 | 1988 | 8 | |
| 17 | 1996 | 7 | |
| 18 | 1989 | 7 | |
| 19 | 1986 | 6 | |
| 20 | 1986 | 6 |
About M Helle
M Helle is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging, Oncology, Genetics and Surgery, having authored 30 papers that have together received 677 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (8 papers), HER2/EGFR in Cancer Research (8 papers), Estrogen and related hormone effects (7 papers), Glycosylation and Glycoproteins Research (6 papers), Ovarian cancer diagnosis and treatment (3 papers), Bladder and Urothelial Cancer Treatments (3 papers), Breast Cancer Treatment Studies (2 papers) and Advanced Biosensing Techniques and Applications (2 papers). The work is most often cited by research in Cancer Research (170 citations), Oncology (206 citations), Reproductive Medicine (53 citations), Pathology and Forensic Medicine (101 citations) and Rheumatology (76 citations). M Helle has collaborated with scholars based in Finland, Japan and Bahrain. Frequent co-authors include Jorma Isola, Heikki J. Helin, Olli Kallioniemi, Kai Krohn, Heikki Helin, Simo Saarakkala, Heikki Hermunen, J. M. Koski, Ullamari Hakulinen and Tapani Liukkonen. Their work appears in journals such as Apmis, American Journal of Clinical Pathology, Journal of Clinical Pathology, Cancer and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.